U.S. FDA rejects psychedelic drug treatment for PTSD. Here’s why
A drugmaker behind an MDMA treatment said the FDA notified the company its drug “could not be approved based on data submitted to date” and requested an additional study.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
